Firethorn Wealth Partners’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$114K Sell
20,340
-61
-0.3% -$383 0.04% 197
2026
Q2
$116K Hold
20,401
– – 0.04% 199
2026
Q1
$87.5K Hold
20,401
– – 0.03% 189
2025
Q4
$183K Hold
20,401
– – 0.07% 186
2025
Q3
$75.5K Buy
20,401
+210
+1% +$572 0.03% 185
2025
Q2
$39.4K Buy
20,191
+139
+0.7% +$290 0.02% 174
2025
Q1
$35.3K Buy
+20,052
New +$45.6K 0.02% 170

Other funds holding NUVB

Firethorn Wealth Partners's NUVB Position: Q3 2026 in Review

Firethorn Wealth Partners reduced its Nuvation Bio (NUVB) stake by 0.3% in Q3 2026, selling an estimated $383 and leaving 20,340 shares worth $114K. The position accounts for 0.04% of the portfolio, ranked #197.

Firethorn Wealth Partners first reported a position in NUVB in Q1 2025 and has held it in 7 quarters since. The position peaked at $183K in Q4 2025. 14 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Firethorn Wealth Partners held 20,340 shares of Nuvation Bio worth $114K as of Q3 2026.
  • Firethorn Wealth Partners sold 61 Nuvation Bio shares in Q3 2026, an estimated $383.
  • Nuvation Bio made up 0.04% of Firethorn Wealth Partners's portfolio in Q3 2026, its #197 holding.
  • Firethorn Wealth Partners first reported a position in Nuvation Bio in Q1 2025 and has held it in 7 quarters since.
  • Firethorn Wealth Partners's Nuvation Bio position peaked at $183K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Firethorn Wealth Partners's 13F filing for Q3 2026, filed 14 Oct 2026.